6.
  
    Lai E, Pratt N, Hsieh C, Lin S, Pottegard A, Roughead E
    
    . Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies. Eur J Epidemiol. 2017; 32(7):567-582.
    
          DOI: 10.1007/s10654-017-0281-8.
    
    
View
   
 
                                          
  7.
  
    Whitaker H, Ghebremichael-Weldeselassie Y, Douglas I, Smeeth L, Farrington C
    
    . Investigating the assumptions of the self-controlled case series method. Stat Med. 2017; 37(4):643-658.
    
          DOI: 10.1002/sim.7536.
    
    
View
   
 
                                          
  8.
  
    Takeuchi Y, Shinozaki T, Matsuyama Y
    
    . A comparison of estimators from self-controlled case series, case-crossover design, and sequence symmetry analysis for pharmacoepidemiological studies. BMC Med Res Methodol. 2018; 18(1):4.
          PMC: 5759844.
    
          DOI: 10.1186/s12874-017-0457-7.
    
    
View
   
 
                                          
  9.
  
    Kuhnert R, Hecker H, Poethko-Muller C, Schlaud M, Vennemann M, Whitaker H
    
    . A modified self-controlled case series method to examine association between multidose vaccinations and death. Stat Med. 2011; 30(6):666-77.
    
          DOI: 10.1002/sim.4120.
    
    
View
   
 
                                          
  10.
  
    Whitaker H, Farrington C, Spiessens B, Musonda P
    
    . Tutorial in biostatistics: the self-controlled case series method. Stat Med. 2005; 25(10):1768-97.
    
          DOI: 10.1002/sim.2302.
    
    
View
   
 
                                          
  11.
  
    Petersen I, Douglas I, Whitaker H
    
    . Self controlled case series methods: an alternative to standard epidemiological study designs. BMJ. 2016; 354:i4515.
    
          DOI: 10.1136/bmj.i4515.
    
    
View
   
 
                                          
  12.
  
    Lewer D, Petersen I, MacLure M
    
    . The case-crossover design for studying sudden events. BMJ Med. 2023; 1(1):e000214.
          PMC: 9978680.
    
          DOI: 10.1136/bmjmed-2022-000214.
    
    
View
   
 
                                          
  13.
  
    Ghebremichael-Weldeselassie Y, Jabagi M, Botton J, Bertrand M, Baricault B, Drouin J
    
    . A modified self-controlled case series method for event-dependent exposures and high event-related mortality, with application to COVID-19 vaccine safety. Stat Med. 2022; 41(10):1735-1750.
          PMC: 9303905.
    
          DOI: 10.1002/sim.9325.
    
    
View
   
 
                                          
  14.
  
    Kulldorff M, Dashevsky I, Avery T, Chan A, Davis R, Graham D
    
    . Drug safety data mining with a tree-based scan statistic. Pharmacoepidemiol Drug Saf. 2013; 22(5):517-23.
    
          DOI: 10.1002/pds.3423.
    
    
View
   
 
                                          
  15.
  
    Wang S, Linkletter C, MacLure M, Dore D, Mor V, Buka S
    
    . Future cases as present controls to adjust for exposure trend bias in case-only studies. Epidemiology. 2011; 22(4):568-74.
          PMC: 3110688.
    
          DOI: 10.1097/EDE.0b013e31821d09cd.
    
    
View
   
 
                                          
  16.
  
    Bots S, Riera-Arnau J, Belitser S, Messina D, Aragon M, Alsina E
    
    . Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries. Front Pharmacol. 2022; 13:1038043.
          PMC: 9730238.
    
          DOI: 10.3389/fphar.2022.1038043.
    
    
View
   
 
                                          
  17.
  
    Maclure M
    
    . The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol. 1991; 133(2):144-53.
    
          DOI: 10.1093/oxfordjournals.aje.a115853.
    
    
View
   
 
                                          
  18.
  
    Luijken K, van Eekelen R, Gardarsdottir H, Groenwold R, van Geloven N
    
    . Tell me what you want, what you really really want: Estimands in observational pharmacoepidemiologic comparative effectiveness and safety studies. Pharmacoepidemiol Drug Saf. 2023; 32(8):863-872.
    
          DOI: 10.1002/pds.5620.
    
    
View
   
 
                                          
  19.
  
    Bots S, Belitser S, Groenwold R, Duran C, Riera-Arnau J, Schultze A
    
    . Applying two approaches to detect unmeasured confounding due to time-varying variables in a self-controlled risk interval design evaluating COVID-19 vaccine safety signals, using myocarditis as a case example. Am J Epidemiol. 2024; 194(1):208-219.
          PMC: 11735966.
    
          DOI: 10.1093/aje/kwae172.
    
    
View
   
 
                                          
  20.
  
    Brown J, Wing K, Leyrat C, Evans S, Mansfield K, Wong A
    
    . Association Between Fluoroquinolone Use and Hospitalization With Aortic Aneurysm or Aortic Dissection. JAMA Cardiol. 2023; 8(9):865-870.
          PMC: 10433140.
    
          DOI: 10.1001/jamacardio.2023.2418.
    
    
View